Intr {#Sec1}
====

The hemodynamic effects of laryngoscopy and endotracheal intubation are well known. A variety of drugs, like fentanyl, esmolol and lately dexmetomidine, have been used in order to attenuate the stress response to laryngoscopy and endotracheal intubation. Esmolol is an ultrashort acting beta 1 selective adrenergic antagonist, while dexmetomidine is an alpha 2 adrenergic receptor agonist. Fentanyl is a short-acting opioid.

Objectives {#Sec2}
==========

The scientific objective of this study, was to compare the efficacy of dexmetomidine, fentanyl and esmolol for attenuation of sympathetic response during laryngoscopy and endotracheal intubation.

Methods {#Sec3}
=======

The present study included sixty (60) elective surgery patients with ASA 1 and 2, aged 20-60 years, who needed endotracheal intubation. Patients were randomly allocated into 3 groups. Each group included twenty patients (n = 20). Patients in group D (Dexmetomidine) received 1mcg/kg dexmetomidine with infusion in 10 min, patients in group F (Fentanyl) received 2 mcg/kg fentanyl, while in group E (Esmolol), patients received 2 mg/kg esmolol two min before induction. All patients had Mallampati and Cormack-Lehane Grades 1 or 2. All patients were intubated in less than 30 sec. Systolic, diastolic, mean arterial pressures and heart rates were measured before induction, before intubation and 1, 2, 4 and 10 min after intubation.

Results {#Sec4}
=======

When recorded values before induction and intubation were compared to the measurements of the groups, it was found that 4 and 10 min after intubation, heart rate in group D and systolic, diastolic and mean arterial pressures in group E, were lower than the other measurements. (p \< 0.05).

Conclusions {#Sec5}
===========

Dexmedetomidine was superior than the other drugs in preventing laryngoscopy and intubation-related tachycardia. On the other hand, esmolol was superior in preventing systolic, diastolic and mean arterial pressure increases following laryngoscopy and intubation.
